Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BIOM3.SA
HoldBiomm S.A. · Healthcare · Brazil · $180M · Avg Vol: $54K/d
42
StockRankGet insider-trade alerts
Q
50
V
38
M
45
P/E (TTM)
28.0x
ROE
10.8%
D/E
0.3x
Dividend %
—
COMPANY DESCRIPTION
Biomm S.A. operates as a biotechnology company in Brazil. The company offers insulin products for the treatment of diabetes, including AFREZZA, a human insulin powder for inhalation; GLARGILIN, a glargine insulin; WOSULIN N and WOSULIN R; Lifepen G, a reusable insulin injection pen; and Biopemm, a...
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 105.0M | 118.2M | 142.9M | 269.3M | 36.9% | 388.7M |
| EPS (BRL) | -1.22 | -0.95 | -0.61 | -0.05 | — | 0.23 |
| Shares | 86.4M | 94.4M | 130.9M | 136.8M | +58.3% | 136.9M |
| Debt | 172.3M | 153.6M | 121.4M | 96.6M | -17.5% | 94.1M |
| Equity | 159.1M | 122.9M | 262.8M | 313.5M | 25.4% | — |
| Op CF | -63.0M | -74.8M | -92.5M | -110.3M | — | -77.1M |
| Inv CF | -6.2M | -2.9M | -38.1M | 22.0M | — | — |
| Fin CF | 113.8M | 25.6M | 180.9M | 33.5M | — | — |
Loading 1Y...
PRICE (1Y)+7.1%
SMA 50SMA 200
Close
$1.22
RSI (14)
52.6
52W High
$2.00
From 52W High
0.6%
SCORE BREAKDOWN
Quality
50
ROIC
7.0%64.2
ROE
10.8%74.2
GP/Assets
26.4%58.8
Op. Margin
10.0%64.6
FCF/Assets
-20.7%21.3
Piotroski
431.8
Int. Cover
2.7x46.5
D/E Ratio
0.29x42.8
Current Ratio
1.55x27.8
Value
38
P/E (TTM)
28.0x42.1
EV/EBITDA
19.2x34.2
P/FCF
—N/A
P/B
2.7x48.6
P/S
2.3x65.1
Div Yield
—N/A
Momentum
45
52W High %
61%36.6
RS 6M
7%70.6
SMA 50/200
0.89x34.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$180M
P/E (Forward)
—
Gross Margin
36.1%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BIOM3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BIOM3.SA | Biomm S.A.(you) | $180M | 42 | Hold |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 57 | Hold |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 74 | Buy |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $382M | 5 | Strong Sell |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 97 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 88 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 84 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 93 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 96 | Strong Buy |
Peer medians: ROE 10.5% · P/E 12.4x · Gross margin 30.3%